BioCentury
ARTICLE | Financial News

Edimer secures $18M in series B

July 31, 2013 12:17 AM UTC

Edimer Pharmaceuticals Inc. (Cambridge, Mass.) secured $18 million in a tranched series B round led by new investor New Enterprise Associates (NEA). New investor Sanofi-Genzyme BioVentures also participated, along with existing investors Third Rock Ventures and VI Partners. NEA's David Mott will join Edimer's board. ...